| GC36673-5mg |
|
883715-22-8 |
N-(3-Methoxybenzyl-(9z,12z)-octadecadienamide
|
0 |
C26H41NO2 |
|
|
|
| GC36672-5mg |
|
29554-26-5 |
N-?Caffeoylputrescine,?(E)?-
|
0 |
C13H18N2O3 |
|
|
|
| GC36672-1mg |
|
29554-26-5 |
N-?Caffeoylputrescine,?(E)?-
|
0 |
C13H18N2O3 |
|
|
|
| GC36671-5mg |
|
883715-18-2 |
|
0 |
C25H37NO |
|
|
|
| GC36670-10mg |
|
— |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
0 |
C2HF3O2 |
|
|
|
| GC36670-5mg |
|
— |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
0 |
C2HF3O2 |
|
|
|
| GC36670-1mg |
|
— |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
0 |
C2HF3O2 |
|
|
|
| GC36668-5mg |
|
1185242-90-3 |
|
0 |
C17H17D3O6 |
|
|
|
| GC36668-1mg |
|
1185242-90-3 |
|
0 |
C17H17D3O6 |
|
|
|
| GC36666-100mg |
|
1421372-66-8 |
|
0 |
C25H31N7O |
|
|
|
| GC36666-50mg |
|
1421372-66-8 |
|
0 |
C25H31N7O |
|
|
|
| GC36666-10mg |
|
1421372-66-8 |
|
0 |
C25H31N7O |
|
|
|
| GC36666-5mg |
|
1421372-66-8 |
|
0 |
C25H31N7O |
|
|
|
| GC36666-2mg |
|
1421372-66-8 |
|
0 |
C25H31N7O |
|
|
|
| GC36666-10mM (in 1mL DMSO) |
|
1421372-66-8 |
|
0 |
C25H31N7O |
|
|
|
| GC36665-100mg |
|
1429180-08-4 |
|
0 |
C25H34N6O3 |
|
|
|
| GC36665-50mg |
|
1429180-08-4 |
|
0 |
C25H34N6O3 |
|
|
|
| GC36665-10mg |
|
1429180-08-4 |
|
0 |
C25H34N6O3 |
|
|
|
| GC36665-5mg |
|
1429180-08-4 |
|
0 |
C25H34N6O3 |
|
|
|
| GC36665-2mg |
|
1429180-08-4 |
|
0 |
C25H34N6O3 |
|
|
|
